Abiopharma

🔍 Coelho Anthony (Director)

Company: Esquire Financial Holdings, Inc. (ESQ)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 20,000 shares of Common Stock at $12.5 per share (Direct)
  Date: 2026-08-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 69,267.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,902 shares of Common Stock at $131.38 per share (Direct)
  Date: 2026-08-07 | Code: F | equity_swap_involved: 0 | shares_owned_after: 67,365.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 12,910.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 36,000.00
• Sold 20,000 shares of Stock Options at $12.5 per share (Derivative)
  Date: 2026-08-07 | Code: M | Expires: 2026-09-01 | Exercise: 2017-09-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F7, F7

Footnotes:

• F1: Includes shares of restricted stock which vest 100% on December 10, 2026.
• F2: Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
• F3: Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
• F4: Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
• F5: Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.
• F6: Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.
• F7: Stock options are fully vested.